Upstream Bio (UPB) Times Interest Earned (2023 - 2026)
Upstream Bio's (UPB) quarterly Times Interest Earned came in at -$2.05 in Q1 2026, up 51.26% year-on-year from -$1.36 in Q1 2025, and down 622.29% quarter-over-quarter from -$0.28 in Q4 2025.
Upstream Bio (UPB) Times Interest Earned (2023 - 2026) Analysis & Trends
Upstream Bio's Times Interest Earned history runs 4 years deep, the most recent figure standing at -$2.05 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 51.26% year-over-year to -$2.05 in Q1 2026; TTM through Mar 2026 was -$8.1, a 35.08% increase from a year earlier, with the FY2025 full-year figure at -$0.99, up 9.44% from the prior year.
- Times Interest Earned retreated to -$2.05 in Q1 2026 per UPB's latest filing, from -$0.28 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.28 in Q4 2025 and bottomed at -$4.22 in Q1 2025.
- The 4-year median for Times Interest Earned is -$0.46 (2024), against an average of -$1.17.
- Across the five-year window, Times Interest Earned declined 2.3% in 2024 and jumped 51.26% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$0.36 in 2023, then decreased by 2.3% to -$0.37 in 2024, then grew by 22.96% to -$0.28 in 2025, then tumbled by 622.29% to -$2.05 in 2026.
- Per Business Quant, the three latest UPB Times Interest Earned figures stand at -$2.05 (Q1 2026), -$0.28 (Q4 2025), and -$0.38 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Upstream Bio | 347.73 Mn | 347.73 Mn | -3.94 Mn | -2.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.05 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -1.12 |
| Mar 31, 2025 | -4.22 |
| Dec 31, 2024 | -0.37 |
| Sep 30, 2024 | -0.54 |
| Dec 31, 2023 | -0.36 |